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Abstract
Study design Clinimetric cross-sectional cohort study in adults with paraplegic spinal cord injury (SCI) and neuropathic
pain (NP).
Objective To assess the reliability of standardized quantitative pain drawings in patients with NP following SCI.
Setting Hospital-based research facility at the Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland.
Methods Twenty individuals with chronic thoracic spinal cord injury and neuropathic pain were recruited from a national
and local SCI registry. A thorough clinical examination and pain assessments were performed. Pain drawings were acquired
at subsequent timepoints, 13 days (IQR 7.8–14.8) apart, in order to assess test-retest reliability.
Results The average extent [%] and intensity [NRS 0–10] of spontaneous NP were 11.3% (IQR 4.9–35.8) and 5 (IQR 3–7),
respectively. Pain extent showed excellent inter-session reliability (intraclass correlation coefficient 0.96). Sensory
loss quantified by light touch and pinprick sensation was associated with larger pain extent (rpinprick=−0.47, p= 0.04;
rlight touch=−0.64, p < 0.01).
Conclusion Assessing pain extent using quantitative pain drawings is readily feasible and reliable in human SCI. Relating
information of sensory deficits to the presence of pain may provide distinct insights into the interaction of sensory deaf-
ferentation and the development of neuropathic pain after SCI.
Introduction
Neuropathic pain (NP) is a frequent complication fol-
lowing spinal cord injuries (SCI) with a large impact on
the individual’s quality of life [1–3]. Current recommen-
dations for the assessment of NP mainly focus on uni-
dimensional measures of pain, such as pain intensity, and
questionnaires to capture concomitant disorders (e.g.,
depression, sleep disturbance) as well as the evaluation of
pain interference with activities of daily living [4].
Assessments of the spatial dimension of NP using quan-
titative pain drawings are usually not part of these r-
ecommendations or the clinical routine. Comprehensive
assessment techniques of the somatosensory system (e.g.,
Quantitative Sensory Testing) that are also recommended
for clinical trials on NP following SCI are often performed
at a particular cutaneous spot within the most painful
area, whereby the spatial extent of pain is not addressed
[5, 6]. Information regarding the distribution of pain is
contained in the International Spinal Cord Injury Pain
Basic Data Set as eight principal areas [7] based on the
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classical body chart designed by Margolis [8]. While such
a format of data collection may be most suitable for cur-
rent databases, it does not allow for an
unbiased quantification of pain extent, as the regions
differ in size and are not delineated along precise anato-
mical landmarks. Moreover, pain extent derived from
quantitative pain drawings may potentially inform our
pathophysiological understanding of NP after SCI by
relating clinical measures of pain (e.g., widespread pain)
to central sensitization processes as previously shown for
other pain conditions [9].
In SCI a thorough assessment of segmental sensory and
motor deficits is part of the state-of-the-art clinical exam-
ination according to the International Standards for Neu-
rological Classification of Spinal Cord Injury (ISNCSCI)
[10]. NP after SCI is then classified with regard to the
neurological level of injury (NLI), with at-level pain being
confined to within the dermatome of the NLI and/or three
dermatomes below the lesion level, and below-level pain
beginning more caudally from three segments below the
NLI [4]. Relating sensory signs from the clinical examina-
tion to the presence of pain is so far limited, as the ISNCSCI
exam does not distinguish between negative or positive
sensory signs (i.e., hypoalgesia or hyperalgesia, respec-
tively) [10]. To this end, the documentation of specific signs
and descriptors associated with NP on standardized body
charts may improve clinical practice and facilitate patient
stratification for mechanism-based treatment approaches
[11, 12].
The aim of this clinimetric study was to assess the
reliability of standardized quantitative pain drawings in
patients with spontaneous NP following SCI.
Methods
Participants
The present study was approved by the local ethics board
‘Kantonale Ethikkommission Zürich’ (reference number:
EK-04/2006) and was part of a larger project, which also
explored changes within spinal segments above the NLI.
For this reason, the study only included people with para-
plegia. Individuals were recruited through the national
Swiss Spinal Cord Injury Cohort Study (SwiSCI) database
and a local registry at the Spinal Cord Injury Center,
Balgrist University Hospital, using the following criteria:
(a) thoracic lesions without conus/cauda involvement in
order to exclude peripheral nerve damage, (b) pain intensity
assessed on a numerical rating scale (NRS) > 4 below the
NLI, (d) time since injury >1 year, and (c) no documented
concomitant neurological conditions. Further exclusion
criteria comprised: (1) age <18 or >75 years, (2) pregnancy,
(3) history, symptoms, or signs of concomitant neurological
conditions other than SCI (e.g., stroke, polyneuropathy), (4)
cancer (in particular with radio-chemotherapy), (5) diabetes.
Clinical and pain phenotyping
A comprehensive clinical assessment (Fig. 1A) was con-
ducted prior to the acquisition of pain drawings. The
assessments included the ISNCSCI examination, and a
detailed pain assessment following the recommendations
of the International Spinal Cord Injury Pain Data Set
(ISCIPDS) including the basic (ISCIPDS:B) and extended
(ISCIPDS:E) version [13, 14]. Both questionnaires provide a
B: Body Charts C: AnalysisA: Clinical Assessments
ISNCSCI Exam
Pain Assessments
• ISCIPDS (basic & extended)
• Bedside Sensory Exam
Fig. 1 Study design. A Clinical and pain assessments, B ventral/dorsal
body charts, C real-world example of a digitalized pain drawing of a
patient with an NLI at T10. Neuropathic at-level pain is colored in
yellow and violet, neuropathic below-level pain in green and light
blue. Shoulder pain corresponds to the red and blue areas. A
dermatome grid adapted from the ISNCSCI exam can be super-
imposed on the drawing in order to determine the segmental dis-
tribution of pain. ISNCSCI: International Standards for Neurological
Classification of Spinal Cord Injury, ISCIPDS: International Spinal
Cord Injury Pain Data Set.
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thorough overview of different domains related to NP after
SCI. During the examination movement-related pain was
specifically asked for and sensory signs associated with NP
were assessed in a bedside sensory exam focusing on the
following modalities: dynamic mechanical allodynia (DMA)
using a standardized brush (SENSELab Brush-05, Somedic,
Sweden), pinprick hypo-/hyperalgesia using a disposable
safety pin, as well as cold allodynia using a 25 °C thermo-
roller (Somedic, Sweden). Pinprick sensation was graded
according to the ISNCSCI examination with an additional
debriefing if the sensation differed from that of the control
area (face). Further sensory readouts were analyzed in a
qualitative manner: A decreased pinprick sensation was
considered mechanical hypoalgesia, while an increased
painfulness was considered mechanical hyperalgesia. Painful
sensations (i.e., burning, stinging, throbbing, pulling) in
response to slight brushing or the cold thermoroller were
considered evidence of allodynia. After that, the pain
drawings were acquired following a standardized protocol.
Acquisition of pain drawings
Two standardized body charts (Fig. 1B) were presented to
the individual on a DIN-A4 paper. The charts included a
frontal and dorsal view of the body. In a standardized way,
individuals were instructed to (a) familiarize themselves
with the body chart including its left/right orientation, (b)
shade the areas where they perceive pain, independently
from type and severity of pain. Furthermore, evoked and
spontaneous pain were differentiated. From the perspective
of a clinimetric study evaluating a novel assessment tool,
we sought to minimize variability as a result of pain fluc-
tuations over time due to environmental, seasonal, or indi-
vidual factors. For these reasons, a retest session was
performed at about 2 weeks after the test session.
Data analysis and statistics
After the examiner manually outlined the borders of the
painful areas on the body charts, pain drawings were
scanned and digitalized using an image analysis software
(Inkscape version 0.48, GPL, USA) as described elsewhere
[15]. The number of pixels per pain drawing was counted,
with any shadings that extend beyond the borders of the
body chart being excluded from the analysis. Pain extent
was then expressed as the percentage of pixels in the frontal
and dorsal view. Pain frequency maps were generated by
superimposing all individual pain drawings. A dermatome
grid (Fig. 1C) based on the ISNCSCI template was used to
differentiate at- from below-level pain based on the standard
taxonomy. The diagnosis of NP was made following current
recommendations [16]. Briefly, typical sensory signs and
symptoms had to be present within the painful area, and the
pain distribution needed to follow a plausible neuroanato-
mical distribution with respect to the lesion level. Clinical
judgment was used to disentangle musculoskeletal pain and
NP. The classification into at- and below-level pain was
performed according to the recommendations of the Inter-
national Association for the Study of Pain taskforce for SCI
pain [4]. For the analyses relating residual sensory function
below the NLI to overall pain extent, NP extent was nor-
malized to the body area below the NLI. Accordingly, for
the pinprick and light touch scores, the residual scores
relative to the NLI were calculated, i.e., the sum sensory
scores within the dermatomes below the NLI were used.
Following this approach, associations of below-level sen-
sory function with below-level pain extent could be
explored.
Most statistical analyses and data visualization were
performed in GraphPad Prism (Version 8). ICCs were cal-
culated using SPSS (Version 25). Normality of data dis-
tribution was tested by visual inspection of data histograms
and the Shapiro–Wilk test. Descriptive statistics (mean with
standard deviation (SD), or median with interquartile range
(IQR), depending on data distribution) were used to report
cohort and pain characteristics. Spearman correlations were
used to explore associations between sensory scores and
pain extent. Test–retest statistics were performed for pain
extent and pain intensity. Intraclass correlation coefficients
(ICCs; two-way mixed models with measures of absolute
agreement) and Bland–Altman analyses were used to assess
reliability. ICC values were characterized as “poor” (<0.40),
“fair” (0.41–0.59), “good” (0.60–0.74), and “excellent”
(0.75–1.00) [17]. The Bland–Altman analysis was carried
out as described elsewhere [18]. Briefly, having tested
whether the mean differences of test 1–test 2 examinations
were significantly different from zero, the limits of agree-
ment, i.e., the coefficient of repeatability (mean ± 1.96 SD)
was calculated and plotted.
Results
Demographics and pain characteristics
Twenty individuals with SCI and NP participated in the
study. A detailed cohort overview including demographics
and pain characteristics is provided in Table 1. Briefly, the
median age was 58.5 years (IQR 53.3–62) and the median
time since injury was 14.5 years (IQR 9.4–22.3). Participants
presented with sensory and motor complete (AIS A, n= 9)
and motor incomplete (AIS C/D, n= 11) lesions. Muscu-
loskeletal pain was present in 50% of individuals (n= 10),
while at-level NP could be identified in 11/20 individuals.
The median duration of NP was 14 years (IQR 9–20) with an
average pain intensity during the last week [NRS 0–10] of
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5 (IQR 3–7). Most individuals developed NP within the first
6 months after injury (n= 17), nine individuals reported pain
already within the first month. Two individuals had a late
onset of NP (≥24 months). Whether this delayed presentation
was due to a secondary neurological deterioration, e.g., syr-
inx formation, could not be retrieved from the available
medical records. Ten out of the 20 individuals received an
anti-neuropathic medication at a stable dose for at least
3 months.
Pain extent, sensory signs and symptoms
The average NP extent was 11.3% (IQR 4.9–35.8), and
musculoskeletal pain extent was 0.9 ± 1.8%. Dynamical
mechanical allodynia was present in 10% of individuals and
associated with at-level NP. At-level cold allodynia was
present in 10% of individuals. Pain drawings of all 20
individuals were superimposed to create spatial frequency
maps of the NP distribution (Fig. 2). There was no sig-
nificant correlation between extent and intensity of NP
(r= 0.33, p= 0.15).
Test–retest reliability of pain extent and intensity
The mean time interval between the test and retest session
was 13 days (IQR 7.8–14.8). The test–retest reliability
measures of NP extent and intensity are shown in Table 2,
and the Bland–Altman plots are presented in Fig. 3.
ICCs showed an excellent reliability for pain extent
(0.96) and intensity (0.91) with a narrow confidence
interval. The biases for pain extent and intensity between
the two testing days were very low, being less than 1%
of the mean NP extent and intensity, respectively.
In addition, the values of NP extent and intensity for
all participants, except for one, lie within the limits of
agreement.
Table 1 Demographical information and basic information on clinical pain.































1 52 f T10 A 1 23.4 <6 23 3 No Yes –
2 55 m T1 A 1 11.8 <12 11 3 No No PGB
3 35 m T11 C 1 14.5 <6 14 4 Yes Yes CB,
PCM, MMZ
4 53 m T5 A 1 20.4 <6 20 3 No No –
5 75 f T10 A 2 14.4 <1 15 7 Yes Yes PGB, GPT
6 59 m T9 D 1 6.7 <1 7 1 Yes Yes –
7 58 m T11 A 2 24.1 <1 24 6 No Yes ATD, CBZ
8 62 m T11 C 1 8.8 <1 9 8 Yes Yes ATD,
PGB, CB
9 36 m T11 A 1 6.7 <1 7 6 No Yes PGB,
Voltaren
10 75 m T10 D 2 13.8 <1 14 7 Yes Yes NA
11 62 m T11 A 1 36.3 <3 36 5 Yes Yes –
12 66 m T3 D 1 19.1 <1 19 8 No No –
13 57 m T2 A 1 3.8 <1 4 5 Yes Yes ATD,
PGB, CB
14 61 m T8 D 2 11 <1 11 5 Yes No –
15 63 m T12 A 1 16.8 <2 17 3 No No –
16 62 m T1 D 1 36.4 ~24 13 4 No No –
17 50 m T3 D 2 21.3 <3 21 5.5 No No –
18 54 m T10 C 1 13.3 <3 13 7 Yes Yes PGB, PCM
19 59 m T12 C 1 37.6 >24 11 9 Yes No –
20 54 f T5 D 2 6.2 <3 6 3 No No AT, MMZ
NLI neurological level of injury, AIS ASIA Impairment Scale,MSK musculoskeletal pain, NP neuropathic pain, PGB pregabalin, CB cannabinoids,
PCM paracetamol, MMZ metamizol, GPT gabapentin, ATD antidepressants, AT amitriptyline.
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Sensory function and pain extent
Normalized NP extent was significantly associated with
sensory loss of light touch (r=−0.64, p < 0.01) and pin-
prick (r=−0.47, p= 0.04) below the NLI. Figure 4 illus-
trates that larger pain extent was correlated with more
impairments of pinprick and light touch scores,
respectively.
Discussion
In the present study a novel assessment tool to quantify
pain extent after SCI is presented. Our data supports the
reliability of standardized, quantitative pain drawings in
the assessment of NP following SCI. The quantification of
pain extent emerged as highly reliable and potentially
provides additional, clinically relevant information relat-
ing the presence of pain to (segmental) sensory deficits.
Interestingly, pain extent was negatively correlated with
residual sensory function below the NLI, potentially
providing important insights into underlying pathophy-
siological mechanisms.
The reliability of quantitative pain drawings has been
previously assessed for musculoskeletal pain syndromes
presenting with widespread, referred pain [15]. For these
conditions, test–retest reliability was assessed using a
novel method based on a digital device [15]. The relia-
bility of self-reported pain extent and location was
excellent [15]. Our approach using a similar method of
analysis showed equally excellent results. For practical
reasons, we used a paper-based version of the pain
Fig. 2 Average NP distribution across all individuals (n= 20). The color bar represents the frequency of NP, with dark colors indicating the
most frequently reported areas of pain. Pain was most often reported within the lower limbs corresponding to the L2–L5 and S1 dermatomes.
Table 2 Reliability coefficients
and Bland–Altman readouts for
NP extent and intensity.
Test–retest reliability measures of NP extent and intensity
ICC 95% CI p value Bias LoA
NP extent [%] 0.96 0.76–0.96 <0.001 1.59 −9.78 to 12.97
NP intensity (NRS [0–10]) 0.91 0.90–0.99 <0.001 0.02 −2.23 to 2.27
The intraclass correlation coefficient values (ICCs) are characterized as follows: “poor” < 0.40, “fair”=
0.41–0.59, “good”= 0.60–0.74, and “excellent”= 0.75–1.00, Bias=mean difference between the two
measurements.
LoA limit of agreement, NRS numeric rating scale, NP neuropathic pain, CI confidence interval.
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drawings, however, as previously reported, completing a
digital drawing or a paper-based one yields comparable
results [19]. The Bland–Altman analyses showed rela-
tively even scattering within reasonable limits of agree-
ment for NP extent, suggesting the absence of consistent
bias at either timepoints. For NP intensity, on the other
hand, there seemed to be an increasing measurement
variability (i.e., poorer reproducibility) at the higher and
lower end of the NRS. Intra-individual fluctuations of
pain intensity were previously shown to be higher for low
pain ratings [20], while fluctuations associated with
higher ratings could possibly indicate temporary exacer-
bations, e.g., pain attacks.
The analysis of pain overlap (i.e., frequency maps)
showed that the pain extent clustered within the lower
lumbar segments. This type of analysis will become parti-
cularly interesting when tracking an individual’s pain extent
longitudinally or as an overview of the main pain dis-
tribution within a specific pain cohort. Having tools like
those described in the present study, which can be readily
implemented into clinical practice will provide the foun-
dation for such analyses in the future. The assessment of the
neuroanatomical distribution of pain is also of crucial
diagnostic importance in NP conditions. Following current
recommendations, NP has to show an anatomically plau-
sible distribution [16], which can be inferred from indivi-
dual pain drawings. As pain following SCI is classified with
regard to the NLI into at-, below- and above-level pain [21],
information regarding location is also of particular interest
in NP following SCI.
While the pain extent derived from standardized pain
drawings informs the clinician about the neuroanatomical
distribution of pain [22], it may also be indicative of
underlying pathophysiological processes, e.g., widespread
pain as a clinical correlate of central sensitization pro-
cesses [23, 24]. For instance in musculoskeletal pain
conditions, pain extent was shown to be associated with
more severe pain reflected in higher ratings on the NRS or
with several direct and indirect measures related to central
sensitization, e.g., painDETECT scores or pressure pain
thresholds [23]. These findings have been discussed in the
context of impaired endogenous pain modulation and
sensitization processes (for review see [25]). Moreover, in
a study on chronic pelvic pain, measures of pain extent
were related to cerebral reorganization and interpreted in
the framework of “pain centralization”, implying that pain
is maintained predominantly by central processes,
detached from peripheral input [9]. Interestingly, as
Fig. 3 Bland–Altman plots showing the absolute test–retest reproducibility of NP extent (left) and the NP intensity (right). NP
neuropathic pain.
Fig. 4 Scatter plots showing correlations of pain extent and resi-
dual sensory scores. Left Correlation of NP extent [%] normalized to
the NLI with residual pinprick sensation below the NLI (r=−0.47,
p= 0.04). Right Correlation of pain extent [%] normalized to the NLI
with residual light touch sensation below the NLI (r=−0.64, p <
0.01). Dotted line= linear fit.
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opposed to musculoskeletal pain conditions, there was
no significant correlation of pain extent with pain intensity
in our cohort of individuals with central NP after SCI. A
possible explanation for this could be related to differ-
ences in the underlying pathophysiology of the two con-
ditions. Whereas musculoskeletal pain is driven by
enhanced peripheral input which then initiates and main-
tains central sensitization [25], NP after SCI may be more
related to spinal and supraspinal maladaptive plasticity,
which, to an indeterminate extent, may be the con-
sequence of deafferentation [26, 27]. Thus, in the case of
musculoskeletal pain, the spatial extent of pain may be the
result of increased responsiveness in nociceptive neurons
(i.e., central sensitization) [23] and is therefore also
accompanied by an increased pain intensity. In NP
after SCI, on the other hand, pain may be primarily dis-
coverable as complex structural and functional changes
rostral to the spinal lesion [28], which may render the
relationship between pain intensity and pain extent less
direct.
Relating changes in sensory function to specific spinal
segments is fundamental in the clinical examination of
patients with SCI and is therefore implemented in the
ISNCSCI exam [10]. However, the exam falls short of
documenting sensory plus signs like allodynia and
hyperalgesia, which may precede the onset of spontaneous
NP after SCI [29]. Standardized pain drawings combined
with bedside sensory testing may close this important
diagnostic gap. Sensory deficits or heightened sensitivity
can be specifically assessed within the painful area or
within adjacent segments. In our cohort, we revealed
sensory plus signs (i.e., dynamical mechanical allodynia
and cold allodynia) confined to the areas of at-level pain
in a subset of individuals. Such information may become
important in the longitudinal assessment of patients
enrolled in clinical trials aimed at enhancing neuroplas-
ticity. Here, the emergence of NP as a complication is a
relevant concern and sensitive assessment tools are lack-
ing so far [30]. Segmental assessments of pain and sen-
sory dysfunction are of paramount importance in order to
be able to relate the presence of pain to the clinical-neu-
rological status, and thereby immediately detect subtle
segmental deteriorations. In trials related to the treatment
of NP, pain extent and segmental involvement relative to
the lesion level could be promising outcome parameters as
they may help to differentiate treatment effects related to
peripheral (i.e., effect on at-level pain) or central com-
ponents (i.e., effects on below-level pain) of the NP
phenotype.
The pathophysiological mechanisms that give rise to
NP after an injury to the spinal cord are complex and
incompletely understood [31, 32]. Our data corroborate
the notion of deafferentation-related pain as pain extent
was negatively correlated with preserved sensory function
of both medial-lemniscal (i.e., light touch) and spinotha-
lamic (i.e., pinprick) modalities below the NLI. A
pathological disruption of spinal cord integrity is asso-
ciated with regional changes around the lesion site ran-
ging from inflammatory reactions, excitotoxicity, and
glial cell activation eventually leading to altered neuronal
excitability and possibly behavioral hypersensitivity [32].
Moreover, anterograde and retrograde degeneration of
ascending or descending projections may result in
impaired endogenous control of afferent nociceptive input
as well as neuronal deafferentation of sensory relay areas
rostral to the spinal cord lesion [33, 34] Damage to per-
ipheral afferent fibers (e.g., compromised nerve roots in
at-level NP) with ensuing ectopic activity may also con-
tribute to the spontaneous pain phenotype [35]. Such a
contribution of peripheral afferent input to central NP is a
timely topic, and was recently proposed as a contributing
mechanism in central post-stroke pain [36].
The present study highlights the reliability of quantitative
pain drawings in the assessment of NP after SCI.
Mechanistically, the relationship between sensory loss and
pain extent reinforces the pathophysiological concept of
deafferentation-related NP. Future studies are warranted to
explore the relationship of markers related to central sen-
sitization and pain extent in SCI. Overall, the method of
quantitative pain drawings can be readily implemented
into the clinical routine and potentially provides added
clinical and pathophysiological information, with the pro-
spect of becoming an outcome measure in SCI clinical
trials.
Limitations
A notable strength of this study is the rigorous exclusion of
concurrent peripheral nerve damage and comorbidities that
may confound the primary outcome, i.e., the extent of
central NP. Although specifically addressed during the
initial interview, the presence of musculoskeletal pain
below the neurological level of injury cannot be con-
clusively ruled out and may contribute to the clinical pain
phenotype. Such a remaining uncertainty is a “common
situation in neurological diagnostics” [16] and there is
currently no hard-and-fast algorithm on how to disentangle
neuropathic from musculoskeletal pain below the neurolo-
gical level of injury.
Data availability
The datasets generated and/or analyzed during the current
study are available from the corresponding author on rea-
sonable request.
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